Patents Assigned to Shenzhen Profound-View Pharma Tech Co., Ltd
  • COPPER NANOCLUSTERS, COMPOSITION COMPRISING THE SAME, AND TREATMENT OF MULTIPLE SCLEROSIS
    Publication number: 20240391792
    Abstract: Treatment of multiple sclerosis with copper nanoclusters (CuNCs).
    Type: Application
    Filed: June 28, 2024
    Publication date: November 28, 2024
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei SUN
  • Copper nanoclusters, composition comprising the same, and treatment of multiple sclerosis
    Patent number: 12060281
    Abstract: Treatment of multiple sclerosis with copper nanoclusters (CuNCs).
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: August 13, 2024
    Assignee: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei Sun
  • Application of AuCs or Substances Containing AuCs in the Preparation of Drugs for Preventing and/or Treating Glaucoma
    Publication number: 20240238443
    Abstract: Disclosed is the use of a gold cluster or a gold cluster-containing substance in the preparation of a drug for preventing and/or treating glaucoma.
    Type: Application
    Filed: March 27, 2024
    Publication date: July 18, 2024
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei SUN
  • Application of AuCs or substances containing AuCs in the preparation of drugs for preventing and/or treating glaucoma
    Patent number: 11969477
    Abstract: Disclosed is the use of a gold cluster or a gold cluster-containing substance in the preparation of a drug for preventing and/or treating glaucoma.
    Type: Grant
    Filed: June 28, 2022
    Date of Patent: April 30, 2024
    Assignee: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei Sun
  • Application of AuCs or Substances Containing AuCs in the Preparation of Drugs for Preventing and/or Treating Glaucoma
    Publication number: 20220323608
    Abstract: Disclosed is the use of a gold cluster or a gold cluster-containing substance in the preparation of a drug for preventing and/or treating glaucoma.
    Type: Application
    Filed: June 28, 2022
    Publication date: October 13, 2022
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei Sun
  • Application of AuCs or substances containing AuCs in the preparation of drugs for preventing and/or treating glaucoma
    Patent number: 11413355
    Abstract: Disclosed is the use of a gold cluster or a gold cluster-containing substance in the preparation of a drug for preventing and/or treating glaucoma.
    Type: Grant
    Filed: November 27, 2017
    Date of Patent: August 16, 2022
    Assignee: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei Sun
  • COPPER NANOCLUSTERS, COMPOSITION COMPRISING THE SAME, AND TREATMENT OF MULTIPLE SCLEROSIS
    Publication number: 20210379101
    Abstract: Treatment of multiple sclerosis with copper nanoclusters (CuNCs).
    Type: Application
    Filed: June 28, 2019
    Publication date: December 9, 2021
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei SUN
  • COPPER NANOCLUSTERS, COMPOSITION COMPRISING THE SAME, AND TREATMENT OF NEURODEGENERATIVE DISEASES
    Publication number: 20210379199
    Abstract: Treatment of neurodegenerative diseases with copper nanoclusters (CuNCs), where the neurodegenerative diseases include Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), spinocerebellar ataxia (SCA), and glaucoma.
    Type: Application
    Filed: June 28, 2019
    Publication date: December 9, 2021
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventors: Taolei SUN, Baisong CHANG
  • COPPER NANOCLUSTERS, THYMINE-MODIFIED HYALURONIC ACID AND POLY(COPPER NANOCLUSTERS), METHOD FOR PREPARING THE SAME, AND APPLICATION THEREOF
    Publication number: 20210354994
    Abstract: Copper nanoclusters (CuNCs), thymine-modified hyaluronic acid (TMHA), and poly(copper nanoclusters) (PCuNCs) are disclosed. In certain embodiments, the TMHA is represented by formula I, wherein the degree of substitution of theymine in the HA is in a range of 1-50%, and wherein n for GlcA-GlcNAc repeats is an integer, from 10 to 10,000.
    Type: Application
    Filed: June 16, 2021
    Publication date: November 18, 2021
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventors: Taolei SUN, Baisong CHANG
  • Application of Substances Containing AuCs in Preparing Medicine for Preventing and Treating Alzheimer's Disease
    Publication number: 20210220395
    Abstract: Disclosed are a pharmaceutical use of a gold cluster and a substance containing the gold cluster and the preparation method and use thereof. The gold cluster and substance containing the gold cluster can inhibit the aggregation of A? and ?-syn, has excellent effects on the levels of cell models and animal models, and can be used to prepare drugs for preventing and treating Alzheimer's disease and/or Parkinson's disease.
    Type: Application
    Filed: April 5, 2021
    Publication date: July 22, 2021
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei SUN
  • Substances Containing AuCs and Preparation Method and Use Thereof
    Publication number: 20210220394
    Abstract: Disclosed are a pharmaceutical use of a gold cluster and a substance containing the gold cluster and the preparation method and use thereof. The gold cluster and substance containing the gold cluster can inhibit the aggregation of A? and ?-syn, has excellent effects on the levels of cell models and animal models, and can be used to prepare drugs for preventing and treating Alzheimer's disease and/or Parkinson's disease.
    Type: Application
    Filed: April 5, 2021
    Publication date: July 22, 2021
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei SUN
  • Application of substances containing AuCs in preparing medicine for preventing and treating Alzheimer's disease
    Patent number: 11058717
    Abstract: Disclosed are a pharmaceutical use of a gold cluster and a substance containing the gold cluster and the preparation method and use thereof. The gold cluster and substance containing the gold cluster can inhibit the aggregation of A? and ?-syn, has excellent effects on the levels of cell models and animal models, and can be used to prepare drugs for preventing and treating Alzheimer's disease and/or Parkinson's disease.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: July 13, 2021
    Assignee: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei Sun
  • Substances containing AuCs and preparation method and use thereof
    Patent number: 11000543
    Abstract: Disclosed are a pharmaceutical use of a gold cluster and a substance containing the gold cluster and the preparation method and use thereof. The gold cluster and substance containing the gold cluster can inhibit the aggregation of A? and ?-syn, has excellent effects on the levels of cell models and animal models, and can be used to prepare drugs for preventing and treating Alzheimer's disease and/or Parkinson's disease.
    Type: Grant
    Filed: April 28, 2019
    Date of Patent: May 11, 2021
    Assignee: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei Sun
  • Substances containing AuCs and preparation method and use thereof
    Patent number: 10729718
    Abstract: Disclosed are a pharmaceutical use of a gold cluster and a substance containing the gold cluster and the preparation method and use thereof. The gold cluster and substance containing the gold cluster can inhibit the aggregation of A? and ?-syn, has excellent effects on the levels of cell models and animal models, and can be used to prepare drugs for preventing and treating Alzheimer's disease and/or Parkinson's disease.
    Type: Grant
    Filed: July 20, 2017
    Date of Patent: August 4, 2020
    Assignee: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei Sun
  • Substances Containing AuCs and Preparation Method and Use Thereof
    Publication number: 20200188428
    Abstract: Disclosed are a pharmaceutical use of a gold cluster and a substance containing the gold cluster and the preparation method and use thereof. The gold cluster and substance containing the gold cluster can inhibit the aggregation of A? and ?-syn, has excellent effects on the levels of cell models and animal models, and can be used to prepare drugs for preventing and treating Alzheimer's disease and/or Parkinson's disease.
    Type: Application
    Filed: September 13, 2018
    Publication date: June 18, 2020
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei SUN
  • Substances Containing AuCs and Preparation Method and Use Thereof
    Publication number: 20200048105
    Abstract: Disclosed are a pharmaceutical use of a gold cluster and a substance containing the gold cluster and the preparation method and use thereof. The gold cluster and substance containing the gold cluster can inhibit the aggregation of A? and ?-syn, has excellent effects on the levels of cell models and animal models, and can be used to prepare drugs for preventing and treating Alzheimer's disease and/or Parkinson's disease.
    Type: Application
    Filed: July 20, 2017
    Publication date: February 13, 2020
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei SUN
  • Substances Containing AuCs and Preparation Method and Use Thereof
    Publication number: 20190321396
    Abstract: Disclosed are a pharmaceutical use of a gold cluster and a substance containing the gold cluster and the preparation method and use thereof. The gold cluster and substance containing the gold cluster can inhibit the aggregation of A? and ?-syn, has excellent effects on the levels of cell models and animal models, and can be used to prepare drugs for preventing and treating Alzheimer's disease and/or Parkinson's disease.
    Type: Application
    Filed: April 28, 2019
    Publication date: October 24, 2019
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei SUN
  • Application of AuCs or Substances Containing AuCs in the Preparation of Drugs for Preventing and/or Treating Glaucoma
    Publication number: 20190175753
    Abstract: Disclosed is the use of a gold cluster or a gold cluster-containing substance in the preparation of a drug for preventing and/or treating glaucoma.
    Type: Application
    Filed: November 27, 2017
    Publication date: June 13, 2019
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei Sun
  • Substances Containing AuCs and Preparation Method and Use Thereof
    Publication number: 20190030070
    Abstract: Disclosed are a pharmaceutical use of a gold cluster and a substance containing the gold cluster and the preparation method and use thereof. The gold cluster and substance containing the gold cluster can inhibit the aggregation of ?? and ?-syn, has excellent effects on the levels of cell models and animal models, and can be used to prepare drugs for preventing and treating Alzheimer's disease and/or Parkinson's disease.
    Type: Application
    Filed: September 13, 2018
    Publication date: January 31, 2019
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei SUN
  • Substances Containing AuCs and Preparation Method and Use Thereof
    Publication number: 20190030069
    Abstract: Disclosed are a pharmaceutical use of a gold cluster and a substance containing the gold cluster and the preparation method and use thereof. The gold cluster and substance containing the gold cluster can inhibit the aggregation of A? and ?-syn, has excellent effects on the levels of cell models and animal models, and can be used to prepare drugs for preventing and treating Alzheimer's disease and/or Parkinson's disease.
    Type: Application
    Filed: September 13, 2018
    Publication date: January 31, 2019
    Applicant: Shenzhen Profound-View Pharma Tech Co., Ltd
    Inventor: Taolei SUN